mRNA-based lipid nanoparticletherapeutic that targets theliver and base-editing in the PCSK9 gene to disrupt PCSK9 proteinproduction to lower LDL cholesterol and treat cardiovascular disease. The gene discussed is PCSK9; the disease is cardiovascular disorder.